NCT02495831View on ClinicalTrials.gov

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Healthy

Interventions

DRUG

Diclofenac sodium

Diclofenac sodium 50 mg single dose

DRUG

Diclofenac sodium and safinamide

Diclofenac 50 mg single dose and safinamide 200 mg single dose

Trial Locations (1)

6864

Cross Research SA, Phase I Unit, Arzo

Sponsors

Collaborators (1)

Cross Research S.A.

All Listed Sponsors

collaborator

Cross Research S.A.

INDUSTRY

lead

Zambon SpA

INDUSTRY